Senior Director, Clinical Lead - Neurodegeneration
Johnson & Johnson
Cambridge, Massachusetts, United States of America
$226,000 to $391,000 usd; not specified; medical, ...
Not specified
Neurodegeneration drug development
Late phase drug development
Clinical strategy execution
Johnson & Johnson is seeking a Senior Director, Clinical Lead for Neurodegeneration to oversee innovative late-phase drug development for Alzheimer's Disease. The role requires extensive experience in clinical research, particularly in CNS drug development, and offers an opportunity to make a significant impact in healthcare innovation
Job Summary
The incumbent will serve as a Clinical Leader in Neurodegeneration, Neuroscience, with a focus on innovative late phase drug development for Alzheimer’s Disease projects.
They will provide strategic, clinical, and scientific support and be accountable for the execution of the clinical strategy, serving as the leader of the cross functional clinical team and a core member of the compound development team (CDT).
Employees are eligible for medical, dental, vision, life insurance, disability, retirement plan, savings plan, and long-term incentive program, along with various paid time off benefits.
Matching Summary
Match Score: 85
Johnson & Johnson is seeking a Senior Director, Clinical Lead for Neurodegeneration to oversee innovative late-phase drug development for Alzheimer's Disease. The role requires extensive experience in clinical research, particularly in CNS drug development, and offers an opportunity to make a significant impact in healthcare innovation.
Salary
$226,000 to $391,000 USD; Not specified; Medical, dental, vision, life insurance, disability, retirement plan, savings plan, long-term incentive program, vacation, sick time, holiday pay, work/personal/family time, parental leave, condolence leave, caregiver leave, volunteer leave, military spouse time-off